F. Navarro

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

C. García-Girón, J. Bosch-Barrera, E. Esteban, 2021, BMC cancer.

Metastatic Renal Cell Carcinoma to the Head and Neck Area

M. Provencio, F. Navarro, P. España, 2000, Tumori.

Exploring histopathological and serum biomarkers in lung adenocarcinoma: Clinical applications and translational opportunities (Review)

M. Ortega, M. A. Sáez, M. Álvarez-Mon, 2022, International journal of oncology.

Testicular Germ Cell Tumor and down Syndrome

M. Provencio, F. Bonilla, F. Navarro, 2000, Tumori.

Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

M. Ortega, M. A. Sáez, M. A. Álvarez-Mon, 2023, Journal of personalized medicine.

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

C. García-Girón, J. Bosch-Barrera, E. Esteban, 2020, BMC Cancer.

Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

Gonzalo Colmenarejo, A. Ramírez de Molina, J. Moreno-Rubio, 2020, Cancer biology & medicine.

Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.

Jose M. Silva, M. Provencio, J. García, 1999, Cancer research.